Can surgery stop kidney cancer in its tracks?
NCT ID NCT00918775
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how well surgery works for people with kidney cancer that has spread to other parts of the body. About 86 patients will have the cancer removed by a surgeon. The goal is to see if this surgery helps them live longer without the cancer coming back.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 2
Tests whether the treatment actually works, and watches for side effects, in a larger group.
- Participants
-
86 people
The number who actually took part.
- Started
-
Jun 2009
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients with histologically or cytologically confirmed renal cell carcinoma (RCC) * Patients have clinical reasons for undergoing a surgical resection of tumor; there are two main categories of patients: * Patients with fully resectable disease as defined by lesions accessible by a surgeon during no more than two separate surgical sessions, and are expected to be rendered surgically no evidence of disease (NED) * Patients undergoing a noncurative procedure for relief of symptoms or for management of threatening lesions * Patients have been deemed resectable by the subspecialty surgeon involved in the patient's care * Patients must give written informed consent prior to initiation of therapy, in keeping with the policies of the institution; patients with a history of major psychiatric illness must be judged able to fully understand the investigational nature of the study and the risks associated with the therapy; the only approved consent is attached to this protocol * Patients must have ability to comply with study and/or follow-up procedures * Members of all races and ethnic groups are eligible for this trial Exclusion Criteria: * Patients must not have active acute infections that could be worsened by surgery or interfere with this study * Patients must not have clinically significant cardiovascular disease, or peripheral vascular disease that creates an unacceptably high operative risk * Patients must not have history of other diseases, metabolic dysfunction, physical examination finding, or clinical laboratory finding giving reasonable suspicion of a disease or condition that contraindicates surgical resection, or render the subject at high risk from treatment complications * Patients must not have a history of uncontrolled severe depression
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Renal cell carcinoma are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can two drugs shrink kidney tumors and their vein clots before surgery?
- Blood test aims to catch Cancer's return earlier
- Can a new drug target Hard-to-Treat kidney and ovarian cancers?
- Personalized dosing could tame kidney cancer Drug's side effects
- Can teaching patients about immunotherapy cut severe side effects?
- Can a year of sunitinib delay kidney Cancer's return after lung surgery?